Correct since the CR raise of last December 2022 and the famous slide 26 of the CR Presentation.
What opportunity has popped up since then?
TGA approval for MDMA & Psilocybin. (Out of left field - no one was anticipating that)
As you would expect and as you have said the BOD grabbed the bull by the horns!
March 16th actually
https://stocknessmonster.com/announcements/ihl.asx-3A614978/
Let's run with this! We already have the experts with Monash and our PSI-GAD program, I bet was the thinking.
(They had this one on the radar anyway ie Ketamine)
Maybe the BOD had to make some re-alignment of priorities!
Income-producing Clinics within 6 months or
our TBI pipeline (IHL-216A) which was going to need a lot of capital for a trial to be conducted within the confines of Public Hospitals.
As you said, we follow the path of least resistance that's what transformational companies do...
Good luck @kingkev
All imo - DYOR - Do not rely on any posts on HC
- Forums
- ASX - By Stock
- IHL
- IHL - INCANNEX - HOLDERS RESEARCH
IHL - INCANNEX - HOLDERS RESEARCH, page-1064
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)